[1] WHO Media Central. Hepatitis B[EB/OL]. (2012-07-15) [2012-09-15]. http:www.who.int/media centre/factsheets/fs204/en/index.html.
[2] Laub O, Rall LB. Synthesis of hepatitis B surface antigen in mammalian cells: expression of the entire gene and the coding region[J]. J Virol, 1983,48(1): 271-280.
[3] HBV life cycle[M/CD]. (2009-07-15) [2012-09-15]. http://v.youku.com/v show/I dXODEONjIyMDg.html.
[4] Krugman S, Giles JP, Hammond J. Hepatitis virus: on the infectivity and antigenicity of the MS-1 and MS-2 strains[J]. J Infect Dis,1970,122(5): 432-436.
[5] Martin-Carbonero L, Soriano V. New paradigms for treating hepatitis B in HIV/hepatitis B virus co-infected patients[J]. J Antimicrob Chemother, 2010,65(3):379-382.
[6] Whitacre DC, Lee BO, Milich DR. Use of hepadnavirus core proteins as vaccine platforms[J]. Expet Rev Vaccines,2009,8(11): 1565-1573.
[7] 王 涛. 重庆啤酒乙肝疫苗[N]. 南方都市报,2011-11-25.
[8] Wang S, Qiu L, Yan X, et al. Loss of microRNA 122 expression in patients with hepatitis B enhances hepatitis B virus replication through cyclin G(1)-modulated P53 activity [J].Hepatology, 2012 ,55(3):730-741.
[9] Edman JC, Gray P, Valenzuela P, et al. Integration of hepatitis B virus sequences and their expression in a human hepatoma cell[J]. Nature, 1980, 286(5772): 535-538.
[10] Zhang W, Han L, Lin C, et al. Surface antibody and cytokine response to recombinant Chinese hamster ovary cell(CHO)hepatitis B vaccine[J].Vaccine,2011,29(37):6276-6282.
[11] Zhang Q, Zhong J, Huan L. Expression of hepatitis B virus surface antigen determinants in Lactococcus lactis for oral vaccination[J]. Microbiol Res,2011,166(2):111-120.
[12] Shen ZY, Zheng WP, Deng YL, et al. Variations in the S and P regions of the hepatitis B virus genome under immunosuppresion in vitro and in vivo[J]. Viral Immunol,2012,25(5):368-378.
[13] Schaefer S. Hepatitis B virus taxonomy and hepatitis B virus genotypes[J]. World J Gastroenterol,2007,13(1):14-21.
[14] Rossettti B, Bianco C, De Luca A.Hepatitis B virus surface antigem serconversion after pegylated inter-feron-alpha treatment in an HIV-infected individual with chronic hepatitis B[J]. Infection, 2012,40(3):347-349.
[15] Young MD,Schneider DL,Zuckerman AJ, et al. Adult hepatitis B vaccination using a novel triple antigen recombinant vaccine[J].Hepatology,2001,34(2):372-376.
[16] 陈 红,邓 瑶,谭文杰,等. 含乙型肝炎病毒S-PreS1基因的DNA疫苗与蛋白颗粒疫苗联合免疫可增强免疫应答[J].生物工程学报,2011,27(1): 95-100. |
